ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

U.S. Preventive Services Task Force Recommends Mammograms For Over-40.

February 22, 2002

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

NCI-Approved Clinical Trials Begun At Groups, Centers

November 30, 2007

NCI Begins Latin American Cancer Research Network

April 10, 2009

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011